查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2000736

外科手套市场：按类型、材质、含粉/不含粉、销售管道、应用和最终用户划分－2026-2032年全球市场预测

Surgical Gloves Market by Type, Material, Powder, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科手套市场价值将达到 26 亿美元，到 2026 年将成长到 27.5 亿美元，到 2032 年将达到 39.6 亿美元，复合年增长率为 6.20%。

主要市场统计数据
基准年 2025 26亿美元
预计年份：2026年 27.5亿美元
预测年份 2032 39.6亿美元
复合年增长率 (%) 6.20%

外科手套产业处于临床安全、供应链复杂性和不断发展的材料科学的交汇点，已成为医疗机构和采购团队的焦点。近年来，对高性能防护屏障的需求不断增长，加之监管力度加大和製造地的转移，相关人员对品质、可追溯性和成本效益的关注度显着提高。本分析整合了影响采购决策和营运风险的当前因素，重点在于材料选择、临床应用和分销方式如何从整体上影响临床结果和医疗预算。

在所有医疗机构中，采购经理必须平衡感染预防的需求与产品舒适度、临床医师偏好等实际因素。同时，製造商面临创新聚合物配方、减少环境影响以及确保批次间品质一致性的压力。因此，筹资策略、验证通讯协定和库存管理实务的变革对于医疗机构的韧性至关重要。本实施方案概述了后续章节的框架，重点介绍决策者可用的策略工具，以在不影响临床疗效的前提下，优化安全性、供应连续性和总体拥有成本 (TCO)。

材料方面的突破、更严格的法规、不断发展的采购管道以及临床实践的变化，正在全面改变供应商和买家的策略。

外科手套市场格局正经历着一场变革性的转变，其驱动因素包括供应商动态、产品系列以及临床实践的改变。首先，材料创新正在加速发展。新型聚合物和改良的丁腈配方拓展了触感灵敏度和减少过敏原的选择范围，迫使临床医生和采购团队重新评估传统的偏好。其次，更严格的法规和品质要求促使人们更加关注无菌性、细胞毒性以及生产可追溯性。因此，能够证明自身符合相关法规的供应商变得越来越有价值。

评估美国关税政策调整对进口的影响（截至 2025 年）对供应链、采购和购买的累积影响。

影响美国贸易和关税政策至2025年的政策变化，正为外科手套价值链增添新的复杂性，其累积效应从原材料采购到医院采购，层层递进。儘管官方关税税率和具体分类随时间而变化，但其整体影响却始终如一。具体而言，不断上涨的进口成本引发了关于製造业回流、供应商选择标准调整的讨论，并促使买家重新评估库存策略，以降低跨境成本波动带来的风险。因此，製造商和经销商正在探索调整合约价格、对冲采购管道风险以及实现供应商多元化等方案，以维持利润率和供应稳定性。

透过综合細項分析，揭示材料选择、临床环境、产品类型、粉末偏好和分销管道如何影响采购决策。

透过全面而非孤立地考虑产品属性、终端用户环境和分销模式，可以获得有意义的市场区隔洞察。乳胶、丁腈橡胶、聚异戊二烯和乙烯基等不同材料各自具有独特的价值提案。乳胶仍具备一些临床医生所青睐的传统性能特征，例如弹性和贴合性。丁腈橡胶具有广泛的耐化学性和低致敏性。聚异戊二烯不含天然橡胶蛋白，触感与乳胶相似。乙烯基仍然是低风险、短时任务的经济之选。这些材料特性与临床应用的需求相互作用。例如，心血管外科、普通外科、整形外科以及整形和重组外科等外科专科对触觉灵敏度、抗穿刺性和无菌性的要求各不相同。

影响美洲、欧洲、中东和非洲以及亚太地区的区域趋势和采购现状，以及这些趋势和现状如何影响采购、合规性和供应可靠性。

区域趋势正显着影响着美洲、欧洲、中东和非洲以及亚太市场的供应韧性、监管预期和采购行为。在美洲，筹资策略往往着重于加强与那些优先考虑物流可靠性和遵守当地法规结构的供应商的关係。同时，买家也考虑近岸外包，以减少跨洋运输中断的影响。相较之下，在欧洲、中东和非洲，不同的监管和报销环境，以及认证协调和各国特定的公共采购规则，都对供应商的准入和合约模式产生了重大影响。

企业采取的竞争性和策略性行动，例如投资于无菌生产能力、可追溯性和服务差异化，决定了长期供应商的选择。

产业重组、垂直整合和技术驱动的差异化正在重塑製造商、契约製造製造商和仲介业者之间的竞争格局。领先的製造商正投资于品管系统、无菌生产线和可追溯性技术，以满足日益增长的临床和监管要求；而契约製造和自有品牌合作伙伴则在灵活性和成本优化方面展开竞争。经销商和直销机构则透过提供诸如灭菌验证支援、临床人员产品培训计画以及数据驱动的库存优化工具等综合服务来提升自身价值提案，从而降低缺货和产品过时的风险。

为增强韧性和客户价值，可采取的策略重点包括多元化采购、以临床为中心的创新以及以服务为导向的商业模式。

产业领导企业应推动一系列合作倡议，以增强供应链韧性、提升产品质量，并使商业性提案适应不断变化的临床需求。首先，应投资多元化的筹资策略，结合区域生产能力、检验的二级供应商和库存缓衝，以降低贸易政策波动和物流中断带来的风险。同时，他们必须加快采用能够解决过敏原问题并提供适用于高级外科手术的触感性能的材料和产品特性，并确保灭菌和品管系统符合日益严格的监管要求。

采用混合研究途径，结合一手访谈、营运评估、监管审查和情境分析，以支持可操作的策略见解。

本研究采用混合方法，结合关键相关人员访谈、营运审计、监管文件审查和供应链图谱分析，以全面了解当前趋势。主要访谈对象包括采购经理、临床终端使用者、生产营运经理和分销合作伙伴，从​​而获得有关选择因素、风险接受度和合约行为的定性见解。作为这些访谈的补充，营运审计和生产评估提供了有关生产能力、灭菌流程和品管系统稳健性的客观指标。

策略挑战的整合，重点阐述了整合采购、品质保证和临床协作如何增强韧性和竞争优势。

总之，材料创新、监管细则的完善、分销模式的转变以及政策主导的供应链压力正在重塑外科手套的市场格局。这些因素共同迫使製造商、经销商和医疗采购商采取更精细的采购、产品差异化和服务策略。积极投资于多元化供应链、无菌生产能力以及以临床医生为中心的产品研发的企业，将更有能力应对关税相关的成本压力和不断变化的临床需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科手套市场：按类型划分

  • 非无菌
  • 已灭菌

第九章 外科手套市场：依材料划分

  • 乳胶
  • 丁腈橡胶
  • 聚异戊二烯
  • 乙烯基塑料

第十章：按粉末类型分類的外科手套市场

  • 无粉
  • 粉状

第十一章 外科手套市场：依通路划分

  • 直销
  • 销售代理
  • 线上零售
    • B2B平台
    • B2C平台

第十二章 外科手套市场：依应用领域划分

  • 心血管外科
  • 一般外科
  • 整形外科
  • 整形和重组外科

第十三章 外科手套市场：依最终用户划分

  • 门诊手术中心
    • 医院相关
    • 独立的
  • 诊所
    • 门诊部
    • 一般诊所
  • 诊断中心
    • 诊断影像中心
    • 病理检查室
  • 医院
    • 私立医院
    • 公立医院

第十四章 外科手套市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 外科手套市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 外科手套市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国外科手套市场

第十八章 中国外科手套市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • Anhui Tianyuan Latex Technology Co.,Ltd.
  • Ansell Limited
  • Asma Rubber Products Pvt. Ltd.
  • B. Braun SE
  • Becton Dickinson and Company
  • Berner International GmbH
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Crown Healthcare Ltd.
  • Cypress Medical Products LLC
  • Dynarex Corporation
  • Harps Holdings Sdn. Bhd
  • Honeywell International Inc.
  • Kimberly-Clark Corporation
  • Kossan Rubber Industries Bhd.
  • Medisafe Technologies
  • Medline Industries, Inc.
  • Medtronic PLC
  • Motex Healthcare Corporation
  • Molnlycke Health Care AB
  • Sara Healthcare Pvt. Ltd.
  • SHOWA Group
  • Smart Glove Corporation Sdn Bhd.
  • Supermax Corporation Berhad
Product Code: MRR-02026C4C915C

The Surgical Gloves Market was valued at USD 2.60 billion in 2025 and is projected to grow to USD 2.75 billion in 2026, with a CAGR of 6.20%, reaching USD 3.96 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.60 billion
Estimated Year [2026] USD 2.75 billion
Forecast Year [2032] USD 3.96 billion
CAGR (%) 6.20%

The surgical gloves sector sits at the intersection of clinical safety, supply chain complexity, and evolving material science, making it a critical focal point for healthcare providers and procurement teams alike. In recent years, rising demand for higher-performance barrier protection, coupled with shifts in regulatory scrutiny and manufacturing geographies, has intensified stakeholder attention on quality, traceability, and cost efficiency. This analysis synthesizes current drivers shaping procurement decisions and operational risk, placing emphasis on how material selection, clinical application, and distribution choices collectively influence clinical outcomes and institutional budgets.

Across healthcare settings, procurement leaders must balance infection prevention imperatives with the practicalities of product comfort and clinician preference. At the same time, manufacturers face pressure to innovate on polymer formulations, reduce environmental footprint, and demonstrate consistent lot-to-lot quality. Consequently, transitions in sourcing strategies, validation protocols, and inventory management practices are increasingly central to institutional resilience. This introduction frames the subsequent sections by highlighting the strategic levers available to decision-makers seeking to optimize safety, supply continuity, and total cost of ownership without compromising clinical performance.

How material breakthroughs, regulatory tightening, evolving procurement channels, and changing clinical practice are collectively altering supplier and buyer strategies

The landscape for surgical gloves is undergoing transformative shifts driven by several converging forces that alter supplier dynamics, product portfolios, and clinical practice. First, material innovation has accelerated; alternative polymers and improved nitrile formulations have expanded options for tactile sensitivity and allergen mitigation, prompting clinicians and procurement teams to reassess prior preferences. Secondly, regulatory and quality expectations are tightening, with increased focus on sterility assurance, cytotoxicity profiles, and manufacturing traceability, which in turn elevates the value of suppliers who can demonstrate robust compliance systems.

Moreover, the distribution and procurement models are evolving as direct sales, distributor partnerships, and digital commerce compete to deliver cost transparency, speed, and customization. This shift is accompanied by an intensified emphasis on sustainability practices across production and packaging, influencing buyer selection criteria beyond unit price. Finally, clinical application patterns-such as growth in ambulatory procedures and specialization of surgical disciplines-are reshaping demand profiles. As a result, strategic winners will be those that align product innovation, regulatory robustness, and flexible go-to-market models to emerging healthcare delivery modalities.

Assessing the cumulative supply chain, sourcing, and procurement consequences of United States tariff policy adjustments affecting imports through 2025

Policy shifts affecting trade and tariffs in the United States through 2025 have imposed a new layer of complexity on the surgical gloves value chain, with cumulative effects reverberating from raw material sourcing to hospital procurement. Although official rates and specific classifications vary over time, the broader implications are consistent: increases in import costs incentivize reshoring conversations, alter supplier selection calculus, and prompt buyers to reassess inventory strategies to mitigate exposure to cross-border cost volatility. In turn, manufacturers and distributors are evaluating options such as contractual price adjustments, hedging procurement pipelines, and diversifying supplier footprints to preserve margin and availability.

In practical terms, healthcare institutions and buying groups are likely to encounter tighter negotiation cycles as suppliers pass through incremental cost pressures or seek longer-term agreements to stabilize volumes. Concurrently, there is an observable acceleration in investment toward domestic or nearshoring capacity among upstream producers, driven by the desire for supply assurance and reduced logistical complexity. Regulatory compliance and certification timelines can lengthen the path to market for new domestic entrants, yet the strategic appeal of reduced tariff exposure makes that transition a viable medium-term response. Ultimately, the cumulative tariff environment emphasizes the need for proactive scenario planning, supplier risk assessment, and collaborative contracting to ensure both fiscal discipline and clinical continuity.

Integrated segmentation analysis revealing how material choices, clinical settings, product type, powder preference, and distribution channels shape procurement decisions

Meaningful segmentation insights emerge when product attributes, end-user environments, and distribution models are considered together rather than in isolation. Material distinctions among latex, nitrile, polyisoprene, and vinyl drive different value propositions: latex still offers legacy performance characteristics in elasticity and fit for some clinicians, nitrile provides broad chemical resistance and reduced allergenicity, polyisoprene approaches latex-like feel without natural rubber proteins, and vinyl remains a cost-effective option for low-risk, short-duration tasks. These material attributes interact with clinical application needs, as surgical specialties such as cardiovascular surgery, general surgery, orthopedic surgery, and plastic and reconstructive surgery demand varying levels of tactile sensitivity, puncture resistance, and sterility assurance.

End-user segmentation further refines procurement strategies because ambulatory surgical centers, clinics, diagnostic centers, and hospitals exhibit distinct volume profiles, purchasing governance, and clinical workflows. Ambulatory surgical centers, whether hospital affiliated or independent, typically prioritize throughput and consistent procedure-specific kits, while clinics-outpatient clinics and polyclinics-focus on a broader set of low-to-medium acuity tasks where non-sterile options and powder-free preferences may predominate. Diagnostic centers such as imaging centers and pathology labs have unique glove requirements that emphasize contamination control and chemical resistance, and hospitals, both private and public, demand scalable sterile supplies aligned with surgical caseloads.

Type segmentation between non-sterile and sterile products directly affects supply chain security and inventory management, as sterile surgical gloves require validated sterilization and cold-chain considerations that extend lead times and qualification barriers. Powder considerations-powder free versus powdered-continue to influence clinician preference and regulatory acceptance, with powder-free options gaining favor where cross-sensitivity and wound contamination concerns are prioritized. Distribution channels of direct sales, distributors, and online retail shape accessibility and purchasing cadence; within online retail, both B2B platforms and B2C platforms are transforming procurement through digital catalogs, analytics-enabled replenishment, and faster comparison-shopping. When these segmentation layers are combined-material, end user, type, powder, distribution channel, and application-they create a multidimensional map that enables suppliers and buyers to target product development, optimize contract terms, and tailor inventory policies to clinical demand patterns.

Regional dynamics and sourcing realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, compliance, and supply reliability

Regional dynamics exert distinct influences on supply resilience, regulatory expectations, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, procurement strategies tend to emphasize consolidated vendor relationships with an eye toward logistical reliability and compliance with local regulatory frameworks, while buyers also evaluate nearshoring to mitigate transoceanic disruption. By contrast, Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement environment where certification harmonization and country-level public procurement rules materially affect supplier access and contracting models.

Asia-Pacific remains a critical production hub for polymer-based protective devices, with complex interdependencies between raw material feedstocks and finished goods manufacturing. As such, shifts in regional export policies, labor dynamics, and environmental compliance are particularly consequential for global supply chains. Across regions, stakeholders are adopting differentiated approaches: contingency sourcing and multi-supplier strategies in the Americas, stringent validation and clinical evidence emphasis in Europe, Middle East & Africa, and strategic supplier relationships and capacity audits in Asia-Pacific. Together, these regional vectors underline the importance of tailored commercial strategies that reflect local regulatory, logistical, and clinical realities while preserving global continuity of supply.

Competitive and strategic company behaviors including investment in sterile capacity, traceability, and service differentiation that determine long-term supplier selection

Competitive dynamics among manufacturers, contract suppliers, and distribution intermediaries are being reshaped by consolidation, vertical integration, and technology-enabled differentiation. Leading producers are investing in quality management systems, sterile manufacturing lines, and traceability technologies to meet heightened clinical and regulatory expectations, while contract manufacturers and private-label partners compete on agility and cost optimization. Distributors and direct-sales organizations are enhancing value propositions by offering integrated services such as sterilization validation support, product training programs for clinical staff, and data-driven inventory optimization tools that reduce stockouts and obsolescence risk.

New entrants and specialty firms focused on advanced polymer formulations and sustainability credentials are creating niche opportunities, particularly where clinical teams seek alternatives to traditional elastomers. Mergers and strategic partnerships are common as firms seek to secure upstream feedstocks or downstream distribution channels, enabling tighter control over lead times and quality. Overall, market participants that demonstrate robust regulatory compliance, operational resilience, and service-oriented commercial models are best positioned to capture long-term institutional relationships and to respond to shifting payer and provider priorities.

Actionable strategic priorities including diversified sourcing, clinical-focused innovation, and service-oriented commercial models to strengthen resilience and customer value

Industry leaders should pursue a set of coordinated actions that strengthen supply resilience, elevate product quality, and align commercial propositions with evolving clinical needs. First, invest in diversified sourcing strategies that combine regional production capacity, validated secondary suppliers, and inventory buffers to reduce exposure to trade-policy shifts and logistical disruptions. At the same time, accelerate adoption of materials and product profiles that address allergen concerns and deliver tactile performance suitable for high-acuity surgical specialties, while ensuring sterilization and quality systems meet tightening regulatory expectations.

Commercially, firms should expand value-added service offerings such as clinician education, sterile validation support, and analytics-enabled inventory management to deepen customer relationships and justify premium positioning. Collaboration between procurement teams and clinical leaders will be essential to implement standardized product formularies, streamline evaluation protocols, and realize predictable demand patterns. Finally, embed sustainability and lifecycle considerations into product development and packaging strategies to align with institutional ESG priorities, recognizing that environmental credentials increasingly factor into long-term supplier selection and contract renewal discussions.

Mixed-method research approach combining primary interviews, operational assessments, regulatory review, and scenario analysis to support actionable strategic insights

This research draws on a mixed-methods approach that integrates primary stakeholder interviews, operational audits, regulatory document review, and supply chain mapping to create a comprehensive view of contemporary dynamics. Primary interviews included procurement leads, clinical end users, manufacturing operations managers, and distribution partners, yielding qualitative insights into preference drivers, risk tolerance, and contractual behaviors. Complementing these interviews, operational audits and manufacturing assessments provided objective measures of production capabilities, sterilization workflows, and quality management system robustness.

Regulatory and standards documentation was reviewed to align product attributes with prevailing certification expectations, while trade and logistics analyses illuminated potential disruption points across sourcing routes. Where appropriate, scenario analysis was applied to stress-test sourcing options against tariff volatility and capacity constraints, enabling pragmatic recommendations. Throughout the research process, data integrity was maintained through triangulation across multiple sources and cross-validation with industry practitioners to ensure that findings reflect operational realities and actionable implications for commercial and clinical stakeholders.

Synthesis of strategic imperatives highlighting how integrated sourcing, quality assurance, and clinical collaboration drive resilience and competitive advantage

In conclusion, the surgical gloves landscape is being reconstituted by material innovation, regulatory refinement, shifting distribution paradigms, and policy-driven supply chain pressures. These factors collectively compel manufacturers, distributors, and healthcare purchasers to adopt more sophisticated sourcing, product differentiation, and service strategies. Organizations that proactively invest in diversified supply footprints, sterile manufacturing capability, and clinician-focused product development will be better positioned to navigate tariff-related cost pressures and evolving clinical requirements.

As providers prioritize both safety and operational efficiency, the suppliers that can demonstrate validated quality systems, traceability, and contextualized commercial solutions will win durable partnerships. The path forward requires integrated planning across procurement, clinical governance, and supplier management to translate intelligence into resilient contracts and clinical continuity. Stakeholders who act decisively to align capabilities with emerging demand patterns and regulatory expectations will secure both clinical trust and commercial advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Gloves Market, by Type

  • 8.1. Non Sterile
  • 8.2. Sterile

9. Surgical Gloves Market, by Material

  • 9.1. Latex
  • 9.2. Nitrile
  • 9.3. Polyisoprene
  • 9.4. Vinyl

10. Surgical Gloves Market, by Powder

  • 10.1. Powder Free
  • 10.2. Powdered

11. Surgical Gloves Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Retail
    • 11.3.1. B2B Platforms
    • 11.3.2. B2C Platforms

12. Surgical Gloves Market, by Application

  • 12.1. Cardiovascular Surgery
  • 12.2. General Surgery
  • 12.3. Orthopedic Surgery
  • 12.4. Plastic & Reconstructive Surgery

13. Surgical Gloves Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital Affiliated
    • 13.1.2. Independent
  • 13.2. Clinics
    • 13.2.1. Outpatient Clinics
    • 13.2.2. Polyclinics
  • 13.3. Diagnostic Centers
    • 13.3.1. Imaging Centers
    • 13.3.2. Pathology Labs
  • 13.4. Hospitals
    • 13.4.1. Private Hospitals
    • 13.4.2. Public Hospitals

14. Surgical Gloves Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Gloves Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Gloves Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Surgical Gloves Market

18. China Surgical Gloves Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Abbott Laboratories
  • 19.7. Anhui Tianyuan Latex Technology Co.,Ltd.
  • 19.8. Ansell Limited
  • 19.9. Asma Rubber Products Pvt. Ltd.
  • 19.10. B. Braun SE
  • 19.11. Becton Dickinson and Company
  • 19.12. Berner International GmbH
  • 19.13. Boston Scientific Corporation
  • 19.14. Cardinal Health Inc.
  • 19.15. Crown Healthcare Ltd.
  • 19.16. Cypress Medical Products LLC
  • 19.17. Dynarex Corporation
  • 19.18. Harps Holdings Sdn. Bhd
  • 19.19. Honeywell International Inc.
  • 19.20. Kimberly-Clark Corporation
  • 19.21. Kossan Rubber Industries Bhd.
  • 19.22. Medisafe Technologies
  • 19.23. Medline Industries, Inc.
  • 19.24. Medtronic PLC
  • 19.25. Motex Healthcare Corporation
  • 19.26. Molnlycke Health Care AB
  • 19.27. Sara Healthcare Pvt. Ltd.
  • 19.28. SHOWA Group
  • 19.29. Smart Glove Corporation Sdn Bhd.
  • 19.30. Supermax Corporation Berhad

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GLOVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL GLOVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GLOVES MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GLOVES MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GLOVES MARKET SIZE, BY NITRILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYISOPRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GLOVES MARKET SIZE, BY VINYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDER FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2B PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GLOVES MARKET SIZE, BY B2C PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GLOVES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GLOVES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GLOVES MARKET SIZE, BY POLYCLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GLOVES MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PATHOLOGY LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GLOVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL GLOVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GCC SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. GCC SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. G7 SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. NATO SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. NATO SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. NATO SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA SURGICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA SURGICAL GLOVES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA SURGICAL GLOVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA SURGICAL GLOVES MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA SURGICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA SURGICAL GLOVES MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA SURGICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA SURGICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA SURGICAL GLOVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA SURGICAL GLOVES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA SURGICAL GLOVES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA SURGICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)